SGMT vs SWK · $403.2M cap vs P/E 34, rev $7.81B
Sagimet Biosciences Inc. Series A Common Stock (SGMT) versus Stanley Black & Decker Inc (SWK) — a side-by-side from cached financials, not a winner call.
Sagimet Biosciences Inc. Series A Common Stock (SGMT) is a biotechnology company listed on NASDAQ.
Stanley Black & Decker Inc (SWK) is a tools & accessories company listed on NYSE.
SGMT does not have a complete income-statement cache yet.
Latest reported SWK revenue for 2026-07-04 was $7.81B. Net income was $410.9M. SWK currently screens at market cap $12.82B and trailing P/E 33.8.
SGMT currently screens at market cap $403.2M. SWK currently screens at market cap $12.82B and trailing P/E 33.8.
Not investment advice. Open the SGMT and SWK stock pages for the full models.
Not investment advice.